Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Carl Zeiss Meditec AG    AFX   DE0005313704

CARL ZEISS MEDITEC AG

(AFX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Carl Zeiss Meditec : achieves EBIT margin of 18.1% in fiscal year 2018/19

share with twitter share with LinkedIn share with facebook
share via e-mail
10/23/2019 | 08:00am EST

DGAP-Ad-hoc: Carl Zeiss Meditec AG / Key word(s): Annual Results
Carl Zeiss Meditec achieves EBIT margin of 18.1% in fiscal year 2018/19

23-Oct-2019 / 13:55 CET/CEST
Update of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


 
Carl Zeiss Meditec achieves EBIT margin of 18.1% in fiscal year 2018/19

Jena, October 23, 2019

As already announced on October 2, 2019, Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of EUR 1,459 million in fiscal year 2018/19 (past year: EUR 1,280.9 million) and has significantly expanded EBIT[1] margin[2], exceeding the initial forecast of 15.0% to 17.5%. Based on today's new assessment, EBIT for fiscal year 2018/19 amounted to approx. EUR 264 million (past year: EUR 197.1 million), leading to an EBIT margin of 18.1%.

Upon publication of preliminary results on October 2, 2019, the company had anticipated a still higher EBIT margin for fiscal year 2018/19.

The shortfall was caused by higher operating expenses in the fourth quarter of fiscal year 2018/19, in part driven by the already announced higher investments in the fields of Surgical Ophthalmology and Digitalization.

Final results for fiscal year 2018/19 will be provided on December 6, 2019.
 
 

Contact for investors and press
Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Tel.: +49 3641 220-116
E-Mail: investors.meditec@zeiss.com

[1] Earnings before interest and taxes (also operating profit, EBIT) refers to a key earnings figure within the Carl Zeiss Meditec Group and is calculated in accordance with IFRS standards (see Annual Report 2017/18, p. 76 for reconciliation).
[2] Calculation: EBIT margin = EBIT / revenue (in %) (see Annual Report 2017/18, p. 76).


23-Oct-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena, Germany
Germany
Phone: +49 (0)3641 220-0
Fax: +49 (0)3641 220-112
E-mail: investors.meditec@zeiss.com
Internet: www.zeiss.de/meditec-ag/ir
ISIN: DE0005313704
WKN: 531370
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 894865

 
End of Announcement DGAP News Service

894865  23-Oct-2019 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=894865&application_name=news&site_id=zonebourse

© EQS 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on CARL ZEISS MEDITEC AG
02/19CARL ZEISS MEDITEC AG : Release according to Article 40, Section 1 of the WpHG [..
EQ
02/17CARL ZEISS MEDITEC AG : Release according to Article 40, Section 1 of the WpHG [..
EQ
02/10CARL ZEISS MEDITEC : Successful start to fiscal year 2019/20 for Carl Zeiss Medi..
EQ
02/10CARL ZEISS MEDITEC AG : 1st quarter results
CO
02/06CARL ZEISS MEDITEC AG : quaterly earnings release
02/03CARL ZEISS MEDITEC AG : Preliminary announcement of the publication of quarterly..
EQ
01/23CARL ZEISS MEDITEC AG : Release according to Article 40, Section 1 of the WpHG [..
EQ
01/20CARL ZEISS MEDITEC AG : Release according to Article 40, Section 1 of the WpHG [..
EQ
2019CARL ZEISS MEDITEC : achieves significant increase in sales and earnings in fisc..
PU
2019CARL ZEISS MEDITEC : achieves significant increase in sales and earnings in fisc..
EQ
More news
Financials (EUR)
Sales 2020 1 591 M
EBIT 2020 284 M
Net income 2020 201 M
Finance 2020 577 M
Yield 2020 0,69%
P/E ratio 2020 48,6x
P/E ratio 2021 43,0x
EV / Sales2020 5,84x
EV / Sales2021 5,25x
Capitalization 9 874 M
Chart CARL ZEISS MEDITEC AG
Duration : Period :
Carl Zeiss Meditec AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARL ZEISS MEDITEC AG
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Average target price 111,73  €
Last Close Price 110,40  €
Spread / Highest target 26,8%
Spread / Average Target 1,20%
Spread / Lowest Target -46,6%
EPS Revisions
Managers
NameTitle
Ludwin Monz President & Chief Executive Officer
Michael Kaschke Chairman-Supervisory Board
Justus Felix Wehmer Chief Financial Officer
Markus Guthoff Member-Supervisory Board
Cornelia Grandy Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
CARL ZEISS MEDITEC AG-2.20%10 737
THERMO FISHER SCIENTIFIC3.85%136 233
DANAHER CORPORATION6.80%113 999
INTUITIVE SURGICAL, INC.4.01%71 316
BOSTON SCIENTIFIC CORPORATION-4.87%59 962
EDWARDS LIFESCIENCES CORPORATION-1.61%49 079